Posted on MSRC (The Multiple Sclerosis Resource Centre) www.msrc.co.uk
Aimspro Latest Update 14th April 2005
Over the past few weeks the subject of Aimspro has been at the forefront of many people's thoughts. There is a great deal of speculation and conjecture about what is happening with this therapy, the company involved and the MHRA.
Proventus, the support group for Aimspro users and those attempting to receive this treatment, have placed a statement on their website www.proventus.org.uk
Whilst there is no doubt that the situation with Daval International and the MHRA is complex, MSRC have been assured by the company that the MHRA are working with Daval International to resolve the current difficulties. The MHRA are intending to meet with Daval International early next week (w/c 18th April) to work out the production side of Aimspro. The 'issues' have arisen as a result of the change in the GMP (Good Manufacturing Practice) rules from the EU in May 2004. The position, as understood at the moment, is that the company "falls between two stools" within this set of regulations and therefore the MHRA is having to look at this as a stand-alone case.
All people receiving Aimspro under the "informed consent" rules are receiving a letter from the company explaining the current situation and what they are doing to resolve it.
MSRC remain in regular contact with Daval International and Proventus and will continue to provide updates as and when any new information is available.
Personal comment. Let's stop bashing this drug and first see what happens with it.